CORCEPT THERAPEUTICS INC Operating Cash Flow
CORCEPT THERAPEUTICS INC (CORT) reported Operating Cash Flow of $16.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $33.54M, a 24.28% decline year-over-year.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$16.77M, a 451.61% decline year-over-year.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $38.45M, a 35.98% decline year-over-year.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $54.48M, a 25.67% decline year-over-year.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2025 was $142.00M, a 28.39% decline from fiscal 2024.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2024 was $198.29M, a 56.53% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2023 was $126.68M, a 5.28% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2022 was $120.32M, a 28.33% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 158 month | Net Cash Provided by (Used in) Operating Activities 161 month | Net Cash Provided by (Used in) Operating Activities 164 month | Net Cash Provided by (Used in) Operating Activities 167 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $16.77M 10-Q · filed 2026-07-29 | $55.22M derived: sum of 3 quarters · filed 2026-07-29 | $109.70M derived: sum of 4 quarters · filed 2026-07-29 | ||||||||
| 2026-03-31 | -$16.77M 10-Q · filed 2026-04-30 | $21.68M derived: sum of 2 quarters · filed 2026-04-30 | $76.16M derived: sum of 3 quarters · filed 2026-04-30 | $120.45M derived: sum of 4 quarters · filed 2026-07-29 | ||||||||
| 2025-12-31 | $38.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $92.93M derived: sum of 2 quarters · filed 2026-02-24 | $137.23M derived: sum of 3 quarters · filed 2026-07-29 | $142.00M 10-K · filed 2026-02-24 | ||||||||
| 2025-09-30 | $54.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $98.78M derived: sum of 2 quarters · filed 2026-07-29 | $103.55M 10-Q · filed 2025-11-04 | $163.61M derived: sum of 4 quarters · filed 2026-07-29 | ||||||||
| 2025-06-30 | $44.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $49.07M 10-Q · filed 2026-07-29 | $109.13M derived: sum of 3 quarters · filed 2026-07-29 | $182.42M derived: sum of 4 quarters · filed 2026-07-29 | ||||||||
| 2025-03-31 | $4.77M 10-Q · filed 2026-04-30 | $5.13M 10-Q · filed 2025-05-05 | $64.83M derived: sum of 2 quarters · filed 2026-04-30 | $138.12M derived: sum of 3 quarters · filed 2026-04-30 | $179.31M derived: sum of 4 quarters · filed 2026-04-30 | |||||||
| 2024-12-31 | $60.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $133.35M derived: sum of 2 quarters · filed 2026-02-24 | $174.54M derived: sum of 3 quarters · filed 2026-02-24 | $198.29M 10-K · filed 2026-02-24 | $198.07M 10-K · filed 2025-02-26 | |||||||
| 2024-09-30 | $73.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $114.48M derived: sum of 2 quarters · filed 2025-11-04 | $138.24M 10-Q · filed 2025-11-04 | $138.77M 10-Q · filed 2024-10-30 | $143.77M derived: sum of 4 quarters · filed 2026-02-24 | |||||||
| 2024-06-30 | $41.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $64.94M 10-Q · filed 2025-07-31 | $64.94M 10-Q · filed 2024-07-29 | $70.47M derived: sum of 3 quarters · filed 2026-02-24 | $123.38M derived: sum of 4 quarters · filed 2026-02-24 | |||||||
| 2024-03-31 | $23.76M 10-Q · filed 2025-05-05 | $29.29M derived: sum of 2 quarters · filed 2026-02-24 | $82.19M derived: sum of 3 quarters · filed 2026-02-24 | $124.48M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||
| 2023-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $58.44M derived: sum of 2 quarters · filed 2026-02-24 | $100.72M derived: sum of 3 quarters · filed 2026-02-24 | $126.68M 10-K · filed 2026-02-24 | $127.04M 10-K · filed 2024-02-15 | |||||||
| 2023-09-30 | $52.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $95.19M derived: sum of 2 quarters · filed 2024-10-30 | $121.15M 10-Q · filed 2024-10-30 | $154.54M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||
| 2023-06-30 | $42.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $68.24M 10-Q · filed 2024-07-29 | $101.63M derived: sum of 3 quarters · filed 2025-02-26 | $135.28M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||
| 2023-03-31 | $25.96M 10-Q · filed 2024-05-01 | $59.34M derived: sum of 2 quarters · filed 2025-02-26 | $92.99M derived: sum of 3 quarters · filed 2025-02-26 | $111.03M derived: sum of 4 quarters · filed 2025-02-26 | ||||||||
| 2022-12-31 | $33.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $67.04M derived: sum of 2 quarters · filed 2025-02-26 | $85.08M derived: sum of 3 quarters · filed 2025-02-26 | $120.32M 10-K · filed 2025-02-26 | ||||||||
| 2022-09-30 | $33.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $51.69M derived: sum of 2 quarters · filed 2023-11-01 | $86.94M 10-Q · filed 2023-11-01 | $136.36M derived: sum of 4 quarters · filed 2024-02-15 | ||||||||
| 2022-06-30 | $18.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $53.29M 10-Q · filed 2023-08-02 | $102.71M derived: sum of 3 quarters · filed 2024-02-15 | $151.42M derived: sum of 4 quarters · filed 2024-02-15 | ||||||||
| 2022-03-31 | $35.25M 10-Q · filed 2023-05-03 | $84.67M derived: sum of 2 quarters · filed 2024-02-15 | $133.38M derived: sum of 3 quarters · filed 2024-02-15 | $177.72M derived: sum of 4 quarters · filed 2024-02-15 | ||||||||
| 2021-12-31 | $49.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $98.13M derived: sum of 2 quarters · filed 2024-02-15 | $142.47M derived: sum of 3 quarters · filed 2024-02-15 | $167.89M 10-K · filed 2024-02-15 | ||||||||
| 2021-09-30 | $48.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $93.04M derived: sum of 2 quarters · filed 2022-11-03 | $118.47M 10-Q · filed 2022-11-03 | $153.54M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||
| 2021-06-30 | $44.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $69.76M 10-Q · filed 2022-08-04 | $104.83M derived: sum of 3 quarters · filed 2023-02-28 | $135.28M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||
| 2021-03-31 | $25.42M 10-Q · filed 2022-05-05 | $60.49M derived: sum of 2 quarters · filed 2023-02-28 | $90.94M derived: sum of 3 quarters · filed 2023-02-28 | $144.12M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||
| 2020-12-31 | $35.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $65.52M derived: sum of 2 quarters · filed 2023-02-28 | $118.70M derived: sum of 3 quarters · filed 2023-02-28 | $151.97M 10-K · filed 2023-02-28 | ||||||||
| 2020-09-30 | $30.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $83.63M derived: sum of 2 quarters · filed 2021-11-03 | $116.90M 10-Q · filed 2021-11-03 | $165.35M derived: sum of 4 quarters · filed 2022-02-15 | ||||||||
| 2020-06-30 | $53.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $86.45M 10-Q · filed 2021-07-29 | $134.91M derived: sum of 3 quarters · filed 2022-02-15 | $173.34M derived: sum of 4 quarters · filed 2022-02-15 | ||||||||
| 2020-03-31 | $33.27M 10-Q · filed 2021-05-06 | $81.72M derived: sum of 2 quarters · filed 2022-02-15 | $120.15M derived: sum of 3 quarters · filed 2022-02-15 | $145.71M derived: sum of 4 quarters · filed 2022-02-15 | ||||||||
| 2019-12-31 | $48.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $86.88M derived: sum of 2 quarters · filed 2022-02-15 | $112.44M derived: sum of 3 quarters · filed 2022-02-15 | $136.12M 10-K · filed 2022-02-15 | ||||||||
| 2019-09-30 | $38.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $63.98M derived: sum of 2 quarters · filed 2020-11-03 | $87.66M 10-Q · filed 2020-11-03 | $109.18M derived: sum of 4 quarters · filed 2021-02-23 | ||||||||
| 2019-06-30 | $25.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $49.24M 10-Q · filed 2020-08-04 | $70.75M derived: sum of 3 quarters · filed 2021-02-23 | $115.26M derived: sum of 4 quarters · filed 2021-02-23 | ||||||||
| 2019-03-31 | $23.68M 10-Q · filed 2020-05-04 | $45.20M derived: sum of 2 quarters · filed 2021-02-23 | $89.70M derived: sum of 3 quarters · filed 2021-02-23 | $104.92M derived: sum of 4 quarters · filed 2021-02-23 | ||||||||
| 2018-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $66.02M derived: sum of 2 quarters · filed 2021-02-23 | $81.23M derived: sum of 3 quarters · filed 2021-02-23 | $115.67M 10-K · filed 2021-02-23 | ||||||||
| 2018-09-30 | $44.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $59.72M derived: sum of 2 quarters · filed 2019-11-07 | $94.15M 10-Q · filed 2019-11-07 | $119.03M derived: sum of 4 quarters · filed 2020-02-24 | ||||||||
| 2018-06-30 | $15.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $49.64M 10-Q · filed 2019-08-01 | $74.52M derived: sum of 3 quarters · filed 2020-02-24 | $85.45M derived: sum of 4 quarters · filed 2020-02-24 | ||||||||
| 2018-03-31 | $34.43M 10-Q · filed 2019-05-09 | $59.31M derived: sum of 2 quarters · filed 2020-02-24 | $70.24M derived: sum of 3 quarters · filed 2020-02-24 | |||||||||
| 2017-12-31 | $24.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $35.81M derived: sum of 2 quarters · filed 2020-02-24 | $60.94M 10-K · filed 2020-02-24 | |||||||||
| 2017-09-30 | $10.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $36.05M 10-Q · filed 2018-11-02 | ||||||||||
| 2017-06-30 | $25.13M 10-Q · filed 2018-08-09 | |||||||||||
| 2016-12-31 | $18.39M 10-K · filed 2019-02-26 | |||||||||||
| 2013-12-31 | -$7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$16.27M derived: sum of 2 quarters · filed 2014-03-14 | -$25.50M derived: sum of 3 quarters · filed 2014-03-14 | -$37.06M 10-K · filed 2014-03-14 | ||||||||
| 2013-09-30 | -$8.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$17.84M derived: sum of 2 quarters · filed 2013-11-12 | -$29.39M 10-Q · filed 2013-11-12 | -$38.13M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2013-06-30 | -$9.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$20.79M 10-Q · filed 2013-08-09 | -$29.53M derived: sum of 3 quarters · filed 2014-03-14 | -$38.76M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2013-03-31 | -$11.55M 10-Q · filed 2013-05-08 | -$20.30M derived: sum of 2 quarters · filed 2014-03-14 | -$29.52M derived: sum of 3 quarters · filed 2014-03-14 | -$37.42M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2012-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$17.97M derived: sum of 2 quarters · filed 2014-03-14 | -$25.86M derived: sum of 3 quarters · filed 2014-03-14 | -$36.02M 10-K · filed 2014-03-14 | ||||||||
| 2012-09-30 | -$9.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$17.12M derived: sum of 2 quarters · filed 2013-11-12 | -$27.28M 10-Q · filed 2013-11-12 | -$33.57M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2012-06-30 | -$7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$18.05M 10-Q · filed 2013-08-09 | -$24.34M derived: sum of 3 quarters · filed 2014-03-14 | -$30.95M derived: sum of 4 quarters · filed 2014-03-14 | ||||||||
| 2012-03-31 | -$10.16M 10-Q · filed 2013-05-08 | -$16.45M derived: sum of 2 quarters · filed 2014-03-14 | -$23.05M derived: sum of 3 quarters · filed 2014-03-14 | -$30.26M derived: sum of 4 quarters · filed 2014-03-14 | -$191.73M 10-Q · filed 2012-05-10 | |||||||
| 2011-12-31 | -$6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$12.90M derived: sum of 2 quarters · filed 2014-03-14 | -$20.11M derived: sum of 3 quarters · filed 2014-03-14 | -$27.40M 10-K · filed 2014-03-14 | -$181.57M 10-K · filed 2012-03-13 | |||||||
| 2011-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$13.81M derived: sum of 2 quarters · filed 2012-11-08 | -$21.11M 10-Q · filed 2012-11-08 | -$26.56M derived: sum of 4 quarters · filed 2013-03-15 | -$175.28M 10-Q · filed 2011-11-08 | |||||||
| 2011-06-30 | -$7.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$14.50M 10-Q · filed 2012-08-09 | -$19.96M derived: sum of 3 quarters · filed 2013-03-15 | -$26.38M derived: sum of 4 quarters · filed 2013-03-15 | -$168.67M 10-Q · filed 2011-08-09 | |||||||
| 2011-03-31 | -$7.29M 10-Q · filed 2012-05-10 | -$12.75M derived: sum of 2 quarters · filed 2013-03-15 | -$19.18M derived: sum of 3 quarters · filed 2013-03-15 | |||||||||
| 2010-12-31 | -$5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$11.88M derived: sum of 2 quarters · filed 2013-03-15 | -$22.29M 10-K · filed 2013-03-15 | |||||||||
| 2010-09-30 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$16.83M 10-Q · filed 2011-11-08 | ||||||||||
| 2010-06-30 | -$10.40M 10-Q · filed 2011-08-09 | |||||||||||
| 2009-12-31 | -$17.97M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |